[Clinical observations of treatment with Lyorodin-depot (Jenapharm)].
According to the indications of fluphenazin decanoate in the long-term treatment in schizophrenia the authors analyse the findings of a simple blind study of Lyorodin-depot on a sample of 20 inpatients. The drug was administered at intervals of 21 days for 18 weeks under clinical surveillance. The method consisted of patients' follow-up on an itemized card, psychological checkups and para-clinical investigations. The analysis of clinical findings reveals the amelioration of symptoms at the parameters accounted for, the favourable evolution low incidence of the side effects that confirms its clinical efficiency and tolerance.
Pirozynski
T
T
Chiriţă
V
V
Cosmovici
N
N
Offenberg
C
C
Chiriac
M E
ME
Marinescu
V
V
Cojocaru
M
M
Berlescu
M
M
Mungiu
A
A
D000328:Adult; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D005260:Female; D005476:Fluphenazine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011581:Psychological Tests; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy; D012565:Schizophrenic Psychology
D003692:Delayed-Action Preparations; C011825:fluphenazine depot; D005476:Fluphenazine
Observaţii clinice asupra tratamentului cu Lyorodin-depôt (Jenapharm).